<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE ichicsr>
<ichicsr lang="en">
<ichicsrmessageheader>
<messagetype>ichicsr</messagetype>
<messageformatversion>2.1</messageformatversion>
<messageformatrelease>1.0</messageformatrelease>
<messagenumb>cb9a4c26-9ffe-11ee-a997-28dfeb6bed73-BIO</messagenumb>
<messagesenderidentifier>simplesafety</messagesenderidentifier>
<messagereceiveridentifier>ss</messagereceiveridentifier>
<messagedateformat>204</messagedateformat>
<messagedate>20230626181518</messagedate>
</ichicsrmessageheader>
<safetyreport>
<safetyreportversion>0</safetyreportversion>



<transmissiondateformat>102</transmissiondateformat>
<transmissiondate>20230626</transmissiondate>
<reporttype>1</reporttype>
<serious>2</serious>










<authoritynumb>3401025835542202300030</authoritynumb>




<sender>

<senderorganization>simplesafety</senderorganization>
</sender>
<receiver>

<receiverorganization>ss</receiverorganization>
</receiver>
<patient>
<patientinitial>unknown</patientinitial>




<patientbirthdateformat>102</patientbirthdateformat>
<patientbirthdate>19920624</patientbirthdate>
<patientonsetage>31</patientonsetage>
<patientonsetageunit>801</patientonsetageunit>


<patientagegroup>5</patientagegroup>
<patientweight>60.0</patientweight>

<patientsex>2</patientsex>




<patientdeath>
<patientdeathdateformat>102</patientdeathdateformat>


</patientdeath><patientdeathcause>

<patientdeathreport>0</patientdeathreport>
</patientdeathcause><medicalhistoryepisode>







<patientmedicalcomment>Bacterial conjunctivitis</patientmedicalcomment>
</medicalhistoryepisode><reaction>
<primarysourcereaction>Eyelid edema</primarysourcereaction>

<reactionmeddrallt>10015985</reactionmeddrallt>



<reactionstartdateformat>102</reactionstartdateformat>
<reactionstartdate>20230624</reactionstartdate>






<reactionoutcome>2</reactionoutcome>
</reaction><drug>
<drugcharacterization>1</drugcharacterization>
<medicinalproduct>Ofloxacin Eye Drops</medicinalproduct>






<drugstructuredosageunit>012</drugstructuredosageunit>






<drugdosageform>Eye Drops Solution</drugdosageform>
<drugadministrationroute>047</drugadministrationroute>


<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>20230623</drugstartdate>
<drugenddateformat>102</drugenddateformat>
<drugenddate>20230624</drugenddate>


<actiondrug>0</actiondrug>


<activesubstance>
<activesubstancename>Ofloxacin Eye Drops</activesubstancename>
</activesubstance>
<drugreactionrelatedness>


<drugassessmentsource>Reporter</drugassessmentsource>
<drugassessmentmethod>Global Introspection</drugassessmentmethod>
<drugresult>probably</drugresult>
</drugreactionrelatedness><drugreactionrelatedness>


<drugassessmentsource>Company</drugassessmentsource>
<drugassessmentmethod>Global Introspection</drugassessmentmethod>
<drugresult>probably</drugresult>
</drugreactionrelatedness></drug><summary>
<narrativeincludeclinical>On the 23rd, the consumer came to the pharmacy claiming itchy eyes and was diagnosed with conjunctivitis. The consumer purchased Ofloxacin eye drops and was told the dosage, 1-2 drops three times a day. After being informed of the precautions, the consumer came to inquire the next day, saying that she had redness, swelling and dryness of the eyes and suspected that it was related to the ofloxacin eye drops, and was advised to stop the medication immediately for observation. The next day, the consumer was followed up by phone call and told that her symptoms had improved.</narrativeincludeclinical>
</summary></patient></safetyreport>
</ichicsr>